MedTrace Logo

Massive Nasal Bleeding in Patients With NPC Received Curative RT

NCT06348485 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1327

Last updated 2024-04-04

No results posted yet for this study

Summary

To investigate the incidence, predictive markers, and survival impact of massive nasal bleeding in nasopharyngeal carcinoma (NPC) patients who received curative radiotherapy (RT) with/without chemotherapy. A total of 1327 patients with previously untreated, biopsy-proven NPC, and no distant metastasis were retrospective reviewed. Investigators analyzed the occurrence rates of massive nasal bleeding between different characteristics and tried to identify important predictive factors. Investigators compared overall survival between patients with and without massive nasal bleeding by Kaplan-Meier method.

Conditions

  • Nasopharyngeal Carcinoma Patients Treated With Curative Radiotherapy

Interventions

OTHER

Patients without massive nasal bleeding

No event of massive nasal bleeding after curative radiotherapy

OTHER

Patients with massive nasal bleeding

Any event of massive nasal bleeding after curative radiotherapy

Sponsors & Collaborators

  • Taichung Veterans General Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1994-12-01
Primary Completion
2019-04-30
Completion
2024-02-29

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06348485 on ClinicalTrials.gov